APA (7th ed.) Citation

Smith, Y. E., Wang, G., Flynn, C. L., Madden, S. F., MacEneaney, O., Cruz, R. G. B., . . . Hill, A. D. K. (2022). Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression. Cancers, 14(5), 1303. https://doi.org/10.3390/cancers14051303

Chicago Style (17th ed.) Citation

Smith, Yvonne E., et al. "Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression." Cancers 14, no. 5 (2022): 1303. https://doi.org/10.3390/cancers14051303.

MLA (9th ed.) Citation

Smith, Yvonne E., et al. "Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression." Cancers, vol. 14, no. 5, 2022, p. 1303, https://doi.org/10.3390/cancers14051303.